External Link Notice

Page Information:

Page Title:
Evacetrapib Fails to Reduce Major Adverse Cardiovascular Events | ScienceDaily

Page Description:
Despite lowering low-density lipoprotein (LDL), known as “bad” cholesterol, while markedly increasing levels of high-density lipoprotein (HDL), or “good” cholesterol, a large clinical trial to investigate the cholesterol drug evacetrapib was discontinued early after a preliminary analysis showed it did not reduce rates of major adverse cardiovascular events, according to new research.

This Page is About:
Cholesterol; Heart Disease; Stroke Prevention; Diseases and Conditions; Hypertension; Triglycerides; Diet and Weight Loss; Pharmaceuticals

NOTICE: By following the "Continue to External Link" above you will be leaving Early Retirement & Financial Independence Community web site and entering a web site hosted by another party. Early Retirement & Financial Independence Community does not have any responsibility for, or control over, any of these sites, their content or their privacy policies. We do not endorse or make any representations about them, or any information, products, or materials found there, or any results that may be obtained from using them. If you decide to access any of the linked third parties, you do so entirely at your own risk.

Other Discussions You Might Enjoy
Thread Thread Starter Forum Replies Last Post
Low-dose aspirin to reduce cancer risk samclem Health and Early Retirement 59 09-18-2018 03:57 PM
Aspirin gets another shot at the podium bld999 Health and Early Retirement 18 03-22-2012 08:22 AM
Daily Aspirin? Or no...? SarahW Health and Early Retirement 16 03-03-2010 03:57 PM
Aspirin a day? travelover Health and Early Retirement 27 11-25-2008 08:40 AM
Aspirin Dawg52 Other topics 34 11-11-2005 04:18 PM


 
All times are GMT -6. The time now is 09:15 PM.
 
Powered by vBulletin® Version 3.8.8 Beta 1
Copyright ©2000 - 2024, vBulletin Solutions, Inc.